<PAPER>
  <mode2 name="NewToolArt2" hasDoc="yes" version="1258"/>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
        <abbrev-journal-title>Environmental Health Perspectives</abbrev-journal-title>
        <issn pub-type="epub">0091-6765</issn>
        <publisher>
          <publisher-name>National Institute of Environmental Health Sciences</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="doi">10.1289/ehp.10885</article-id>
        <article-id pub-id-type="publisher-id">ehp0116-000520</article-id>
        <article-categories>
          <subj-group>
            <subject>Research</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>
            <s sid="1">Angiogenic Potential of 3-Nitro-4-Hydroxy Benzene Arsonic Acid (Roxarsone)<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
          </article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Basu</surname>
              <given-names>Partha</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp0116-000520">
              <sup>1</sup>
            </xref>
            <xref ref-type="corresp" rid="c1-ehp0116-000520"/>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Ghosh</surname>
              <given-names>Richik N.</given-names>
            </name>
            <xref ref-type="aff" rid="af2-ehp0116-000520">
              <sup>2</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Grove</surname>
              <given-names>Linnette E.</given-names>
            </name>
            <xref ref-type="aff" rid="af3-ehp0116-000520">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Klei</surname>
              <given-names>Linda</given-names>
            </name>
            <xref ref-type="aff" rid="af4-ehp0116-000520">
              <sup>4</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Barchowsky</surname>
              <given-names>Aaron</given-names>
            </name>
            <xref ref-type="aff" rid="af4-ehp0116-000520">
              <sup>4</sup>
            </xref>
          </contrib>
        </contrib-group>
        <aff id="af1-ehp0116-000520">
          <label>1</label>
          <addr-line>Department of Chemistry and Biochemistry, Duquesne University, Pittsburgh, Pennsylvania, USA</addr-line>
        </aff>
        <aff id="af2-ehp0116-000520">
          <label>2</label>
          <addr-line>Thermo Fisher Scientific, Rockford, Illinois, USA</addr-line>
        </aff>
        <aff id="af3-ehp0116-000520">
          <label>3</label>
          <addr-line>Thermo Fisher Scientific, Pittsburgh, Pennsylvania, USA</addr-line>
        </aff>
        <aff id="af4-ehp0116-000520">
          <label>4</label>
          <addr-line>Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA</addr-line>
        </aff>
        <author-notes>
          <corresp id="c1-ehp0116-000520">Address correspondence to P. Basu, Department of Chemistry and Biochemistry, 600 Forbes Ave., Duquesne University, Pittsburgh, PA 15282 USA. Telephone: (412) 396-6345. Fax: (412) 396-5683. E-mail: <email xlink:type="simple">basu@duq.edu</email></corresp>
          <fn>
            <p>L.E.G. and R.N.G. are employees of Thermo Fisher Scientific. P.B., L.K., and A.B. are employees of nonprofit educational organizations with no competing financial interests.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <season>April</season>
          <year>2008</year>
        </pub-date>
        <pub-date pub-type="epub">
          <day>17</day>
          <month>1</month>
          <year>2008</year>
        </pub-date>
        <volume>116</volume>
        <issue>4</issue>
        <fpage>520</fpage>
        <lpage>523</lpage>
        <history>
          <date date-type="received">
            <day>13</day>
            <month>9</month>
            <year>2007</year>
          </date>
          <date date-type="accepted">
            <day>15</day>
            <month>1</month>
            <year>2008</year>
          </date>
        </history>
        <copyright-statement>This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <abstract>
          <sec>
            <title>Background</title>
            <p>
              <s sid="2">Roxarsone (3-nitro-4-hydroxy benzene arsonic acid) is an arsenic compound widely used in the poultry industry as a feed additive to prevent coccidiosis, stimulate growth, and to improve tissue pigmentation.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/></s>
              <s sid="3">Little is known about the potential human health effects from roxarsone released into the environment from chicken waste or from residual compound in chicken products.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Objective</title>
            <p>
              <s sid="4">The growth potentiation and enhanced tissue pigmentation suggest that low levels of roxarsone exposure may have an angiogenic potential similar to that of inorganic arsenite (As<sup>III</sup>).<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/></s>
              <s sid="5">The goal of this investigation was to test the hypothesis described above using cultured human aortic and lung microvascular endothelial cells in high-content imaging tube-forming assays and begin developing a molecular level understanding of the process.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Methods</title>
            <p>
              <s sid="6">We used a three-dimensional Matrigel assay for probing angiogenesis in cultured human endothelial cells, and a polymerase chain reaction (PCR) array to probe the gene changes as a function of roxarsone or As<sup>III</sup> treatment.<CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/></s>
              <s sid="7">In addition, we used Western blot analysis for changes in protein concentration and activation.<CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Results</title>
            <p>
              <s sid="8">Roxarsone was found to exhibit a higher angiogenic index than As<sup>III</sup> at lower concentrations.<CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
              <s sid="9">Increased endothelial nitric oxide synthase (eNOS) activity was observed for roxarsone but not for As<sup>III</sup>-induced angiogenesis.<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
              <s sid="10">However, As<sup>III</sup> caused more rapid and pronounced phosphorylation of eNOS.<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/></s>
              <s sid="11">Quantitative PCR array on select genes revealed that the two compounds have different and often opposite effects on angiogenic gene expression.<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Conclusions</title>
            <p>
              <s sid="12">The results demonstrate that roxarsone and As<sup>III</sup> promote angiogenic phenotype in human endothelial cells through distinctly different signaling mechanisms.<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>angiogenesis</kwd>
          <kwd>animal feed</kwd>
          <kwd>arsenic</kwd>
          <kwd>gene expression</kwd>
          <kwd>nitric oxide</kwd>
          <kwd>roxarsone</kwd>
          <kwd>tube formation</kwd>
        </kwd-group>
      </article-meta>
    </front>
    <body>
      <p>
        <s sid="13">Arsenic contamination of drinking water is a worldwide public health concern.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
        <s sid="14">The extent of the concern in some countries has reached a point such that some are calling this humanity&#8217;s largest mass poisoning (<xref ref-type="bibr" rid="b4-ehp0116-000520">Bhattacharjee 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
        <s sid="15">Even low levels of exposure to arsenic have been linked to increased cardiovascular disease and hypertension (<xref ref-type="bibr" rid="b9-ehp0116-000520">Chen et al. 2007</xref>; <xref ref-type="bibr" rid="b20-ehp0116-000520">Navas Acien et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
        <s sid="16">Although natural contamination of drinking water with inorganic arsenic represents the largest arsenical hazard to human health, environmental exposure to commercial organoarsenicals is a growing concern (<xref ref-type="bibr" rid="b22-ehp0116-000520">Sapkota et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
        <s sid="17">Organoarsenicals such as roxarsone are widely used by the poultry industry (<xref ref-type="bibr" rid="b1-ehp0116-000520">Arai et al. 2003</xref>; <xref ref-type="bibr" rid="b5-ehp0116-000520">Brown et al. 2004</xref>; <xref ref-type="bibr" rid="b8-ehp0116-000520">Chapman et al. 2002</xref>), with approximately 2.2 million pounds of roxarsone being fed to broiler chickens raised in the United States per year (<xref ref-type="bibr" rid="b12-ehp0116-000520">Garbarino et al. 2003</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
        <s sid="18">The majority of roxarsone is excreted unchanged from chickens (<xref ref-type="bibr" rid="b19-ehp0116-000520">Morrison 1969</xref>), while the remainder increases the total arsenic present in chicken tissue (<xref ref-type="bibr" rid="b16-ehp0116-000520">Lasky et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="19">This residual roxarsone could amount to ingestion of 1.38&#8211;5.24 mg/day of arsenic at mean levels of chicken consumption (60 g/person/day) (<xref ref-type="bibr" rid="b29-ehp0116-000520">Wallinga 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
        <s sid="20">The excreted roxarsone may pose an environmental hazard, as microbes, including those residing in the gut microflora, can release inorganic arsenite (As<sup>III</sup>) from roxarsone (<xref ref-type="bibr" rid="b26-ehp0116-000520">Stolz et al. 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
        <s sid="21">The human health impacts of roxarsone have not been well studied, and the mechanisms for its biological effects in mammalian tissues are unknown.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/></s>
        <s sid="22">It has been suggested, however, that all of these biological effects require metabolism to inorganic As<sup>III</sup> (<xref ref-type="bibr" rid="b21-ehp0116-000520">O&#8217;Connor et al. 2005</xref>).<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="23">In a variety of <italic>in vivo</italic> and <italic>in vitro</italic> models, nanomolar or low micromolar concentrations of arsenic (As<sup>III</sup>) stimulate angiogenesis and vascular remodeling that may promote vascular diseases and tumorigenesis (<xref ref-type="bibr" rid="b15-ehp0116-000520">Kamat et al. 2005</xref>; <xref ref-type="bibr" rid="b17-ehp0116-000520">Liu et al. 2006</xref>; <xref ref-type="bibr" rid="b24-ehp0116-000520">Soucy et al. 2003</xref>, <xref ref-type="bibr" rid="b25-ehp0116-000520">2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="24">In addition to enhancing tumor growth, increased angiogenesis would contribute to overall growth potential and increased tissue pigmentation.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="25">These are the attributes of roxarsone that contribute to its widespread use; however, the cellular effects of roxarsone to mammalian cells are not known.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/></s>
        <s sid="26">Further, it is unclear whether the vascular effects of roxarsone are dependent on its metabolism to inorganic arsenic.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot4" novelty="None" advantage="None"/></s>
        <s sid="27">Herein we report the angiogenic potential of roxarsone and compare it with that of inorganic arsenite (As<sup>III</sup>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
        <s sid="28">In addition, we report different modes of action of these two compounds in promoting angiogenesis.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="None" advantage="None"/></s>
      </p>
      <sec sec-type="materials|methods">
        <title>Materials and Methods</title>
        <sec>
          <title>Culture of endothelial cells</title>
          <p>
            <s sid="29">Human aortic endothelial cells (HAEC) and lung microvascular endothelial cells (HMVEC) (Clonetics; Lonza, Walkersville, MD, USA) were cultured at 5% CO<sub>2</sub> in complete MCDB 131 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 5% fetal calf serum (Hyclone; Thermo Fisher Scientific, Pittsburgh, PA, USA), 1% pen/strep, 1% hydrocortisone, 2 mM <sc>l</sc>-glu-tamine, and 10 ng/mL epidermal growth factor (Sigma-Aldrich Chemical Co., St. Louis, MO, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
            <s sid="30">Under these conditions up to 10 &#181;M roxarsone was not cytotoxic, as determined by dye exclusion assays, whereas As<sup>III</sup> was toxic at 10 &#181;M but not at 5 &#181;M (<xref ref-type="bibr" rid="b2-ehp0116-000520">Barchowsky et al. 1999a</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
            <s sid="31">Cells were used at passages 6&#8211;7 in three-dimensional Matrigel matrix cultures to probe the angiogenic potential (tube formation) of roxarsone and As<sup>III</sup>.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>Three-dimensional angiogenic tube-formation assay</title>
          <p>
            <s sid="32">Concentration-responsive effects of roxarsone and As<sup>III</sup> on the angiogenic potential of HAEC and HMVEC were compared in quantitative high-content cellular imaging tube-formation assays in Matrigel (BD Biosciences, San Jose, CA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
            <s sid="33">Cells were incubated for 24 hr in reduced serum and growth factor MCDB 131 (1:5 dilution of complete MCDB 131 with nonsupplemented MCDB 131).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
            <s sid="34">The cells were then released from the culture dish with trypsin, diluted in MCDB 131 with or without inhibitors, and 6,000&#8211;10,000 cells were plated onto 35-mL Matrigel cushions in 96-well plates.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
            <s sid="35">Sodium arsenite (As<sup>III</sup>)) or roxarsone was then added from 1,000&#215; stock solutions.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
            <s sid="36">As positive controls for angiogenic tube formation, either vascular endothelial growth factor (1 ng/mL) or a cocktail of growth factors (vascular endothelial growth factor, 10 ng/mL; fibro-blast growth factor, 10 ng/mL; erythropoietin, 2 U/mL; and interleukin-6, 10 ng/mL) were added to the cultures.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/></s>
            <s sid="37">After 16 hr, the medium was removed and the gels were air dried.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/></s>
            <s sid="38">Rhodamine-labeled phalloidin and 4'-6-diamidino-2-phenylindole (DAPI; (Sigma-Aldrich) were added to stain F-actin and nuclei, respectively.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/></s>
            <s sid="39">Images of fluorescently labeled cells were collected with a Thermo Scientific Cellomics ArrayScan HCS Reader (Thermo Fisher Scientific, Pittsburgh, PA, USA) and analyzed by an automated algorithm that identified the tubes formed by the association and clustering of the endothelial cells.<CoreSc1 atype="GSC" type="Mod" conceptID="Mod1" novelty="None" advantage="None"/></s>
            <s sid="40">This algorithm provided quantitative measurements of tube properties such as the number of tubes, tube lengths, tube areas, number of nodal branch points, and the angiogenic index&#8212;defined as the percentage of image area covered by tubes multiplied by 10 (<xref ref-type="bibr" rid="b13-ehp0116-000520">Ghosh et al. 2007</xref>; <xref ref-type="bibr" rid="b14-ehp0116-000520">Grove and Ghosh 2006</xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj5" novelty="None" advantage="None"/></s>
            <s sid="41">Each experiment was repeated 3 times, and each treatment was probed in at least six wells.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/></s>
            <s sid="42">Differences between treatments were analyzed by one- and two-way analysis of variance (ANOVA) and Dunnett or Bonferroni post hoc tests for significance using Graphpad Prism v4.0 software (Graphpad Software, San Diego, CA, USA).<CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec>
          <title>SuperArray Angiogenesis RT2 Profiler PCR array</title>
          <p>
            <s sid="43">The effects of 24-hr exposures to As<sup>III</sup> and roxarsone on HMVEC mRNA levels for 84 angiogenic and 5 constitutive genes were measured using the SuperArray quantitative polymerase chain reaction (PCR) assay (SuperArray Bioscience Corp., Frederick, MD, USA).<CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
            <s sid="44">Total RNA was extracted from approximately 500,000 cells using QIAGEN RNeasy (QIAGEN, Chatsworth, TN, USA) mini kits with inclusion of a DNase treatment step.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/></s>
            <s sid="45">First-strand cDNA synthesis and quantitative real-time PCR with SYBR green master mix was performed in an Opticon 2 DNA engine (BioRad Corp., Hercules, CA, USA) according to the manufacturer&#8217;s instructions.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Western analysis</title>
          <p>
            <s sid="46">Western blot analysis was performed on proteins isolated from HAEC exposed to As<sup>III</sup> or roxarsone for 0.5, 1, or 4 hr.<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/></s>
            <s sid="47">The proteins were separated by sodium dodecyl sulfate&#8211;polyacrylamide gel electrophoresis and transferred to polyvinylidene membranes, as previously described (<xref ref-type="bibr" rid="b3-ehp0116-000520">Barchowsky et al. 1999b</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
            <s sid="48">Blots were probed with primary antibody to either total or ser1177 phosphorylated eNOS (Cell Signaling Technologies, Danvers, MA, USA) and reacted bands were detected by horseradish peroxidase&#8211;conjugated secondary antibodies and enhanced chemiluminescence substrates (PerkinElmer, Boston, MA, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/></s>
            <s sid="49">Density of bands on film exposed to blots was determined using Scion Image software (Scion Corp., Frederick, MD, USA).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="display-objects">
        <title>Figures and Tables</title>
        <fig id="f1-ehp0116-000520" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Images of fluorescent-labeled HAEC (10,000 cells/well) treated with different concentrations of roxarsone. HAEC were grown on a thin layer of Matrigel in a 96-well plate, treated for 16 hr, then fixed and fluorescently labeled with rhodamine&#8211;phalloidin (?<italic><sub>ex</sub></italic> ~ 542 nm, ?<italic><sub>em</sub></italic> ~ 565 nm) to delineate the cell and tube structures. Images were acquired on a Thermo Scientific Cellomics ArrayScan HCS Reader using a 5&#215; microscope objective (lengths of images shown are 1,400 &#181;m, and scale bar in the negative control panel is 350 &#181;m), and analyzed by an automated algorithm for quantifying tube morphology. Grayscale fluorescence images are shown with colored overlays from the algorithm identifying the different entities measured: connected tubes are outlined in blue, unconnected objects are in aqua, nodes where the tube branches are marked by pink dots, and objects rejected from the quantitative analysis are in orange.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.10885.g001" xlink:type="simple"/>
        </fig>
        <fig id="f2-ehp0116-000520" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Angiogenic index obtained directly from the image processing of the tube formation assay on HAEC. &#8220;No treatment&#8221; refers to the negative control, which had no treatment, and the cells were grown on serum-free basal media; GF refers to a mixture of growth factors used as a positive control (VEGF, 10 ng/mL; fibroblast growth factor, 10 ng/mL; erythropoietin, 2 U/mL; and interleukin-6, 10 ng/mL). As and Rox refer to As<sup>III</sup> and roxarsone, respectively. In each case, data were collected from six wells, and five different fields were imaged for each well. The angiogenic index &#177; SD is plotted for each condition. Error bars indicate SDs.</p>
            <p>*<italic>p</italic> &lt; 0.05 and **<italic>p</italic> &lt; 0.01 determined from one-way ANOVA analysis, followed by the Dunett post-test.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.10885.g002" xlink:type="simple"/>
        </fig>
        <fig id="f3-ehp0116-000520" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Effects of L-NAME (<italic>A</italic> ) and D-NAME (<italic>B</italic> ) on angiogenic index. HAEC were treated as follows: (a) no treatment, (b) a mixture of growth factors as a positive control, (c) roxarsone (0.1 &#181;M), and (d) As<sup>III</sup> (0.1 &#181;M). Open bars represent cells with no NAME; blue bars represent cells treated with different isomers of NAME (50 &#181;M). In each case, 12 wells were investigated, and each well was imaged at five different fields. Angiogenic index &#177; SD is plotted in each case.</p>
            <p>*<italic>p</italic> &lt; 0.05 and ***<italic>p</italic> &lt; 0.001 determined from two-way ANOVA analysis, followed by the Bonferroni post-test.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.10885.g003" xlink:type="simple"/>
        </fig>
        <fig id="f4-ehp0116-000520" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Western blot showing phosphorylated eNOS (p-eNOS) (<italic>A</italic>), and total eNOS (<italic>B</italic>) in HAEC. Proteins were loaded equally after protein determination, which was confirmed by probing beta-actin (data not shown). Conditions: NC, no additional treatment; GF, a mixture of grown factors as positive control as described in <xref ref-type="fig" rid="f2-ehp0116-000520">Figure 2</xref>; Rox, 1 &#181;M roxarsone; As, 1 &#181;m As<sup>III</sup>. All lanes on the gels were generated using proteins from separate cell cultures. Two replicates were done for each condition and were also used for statistical analyses. Individual bands were analyzed using Scion Image program, and the percent eNOS phosphorylated with respect to total is plotted for each condition (mean &#177; SD).</p>
            <p>*<italic>p</italic> &lt; 0.05 and ***<italic>p</italic> &lt; 0.001 determined from two-way ANOVA analysis, followed by the Dunnett post-test.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.10885.g004" xlink:type="simple"/>
        </fig>
        <table-wrap id="t1-ehp0116-000520" position="float">
          <label>Table 1</label>
          <caption>
            <p>Angiogenic index of the response to arsenicals by different endothelial cells.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.10885.t001" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t2-ehp0116-000520" position="float">
          <label>Table 2</label>
          <caption>
            <p>SuperArray Angiogenesis RT<sup>2</sup> Profiler PCR array for angiogenic genes.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.10885.t002" xlink:type="simple"/>
        </table-wrap>
      </sec>
      <sec sec-type="results|discussion">
        <title>Results and Discussion</title>
        <p>
          <s sid="50">Concentration-responsive effects of roxarsone and As<sup>III</sup> on the angiogenic potential of HAEC and HMVEC were compared in quantitative high-content cellular imaging tube-formation assays in Matrigel (<xref ref-type="fig" rid="f1-ehp0116-000520">Figure 1</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
          <s sid="51">Images of fluorescently labeled cells were analyzed by an algorithm that identified the angiogenic tubes formed by the association and clustering of the endothelial cells and quantitatively measured the properties of the identified tubes such as the number of tubes, tube lengths, tube areas, number of nodal branch points, and the angiogenic index.<CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="None" advantage="None"/></s>
          <s sid="52">The angiogenic index is defined as the percentage of image area covered by tubes multiplied by 10 (<xref ref-type="bibr" rid="b13-ehp0116-000520">Ghosh et al. 2007</xref>; <xref ref-type="bibr" rid="b14-ehp0116-000520">Grove and Ghosh 2006</xref>).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj6" novelty="None" advantage="None"/></s>
          <s sid="53">Both compounds were as effective as vascular endothelial cell growth factor (VEGF) in increasing the angiogenic index above the value for untreated control cells in both cell types (<xref ref-type="fig" rid="f1-ehp0116-000520">Figures 1</xref> and <xref ref-type="fig" rid="f2-ehp0116-000520">2</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/></s>
          <s sid="54">Both cell types exhibited strong angiogenic responses with the arsenical treatments; however, the HMVEC showed a higher basal level of angiogenesis (<xref ref-type="table" rid="t1-ehp0116-000520">Table 1</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/></s>
          <s sid="55">Because of their lower basal angiogenic activity, HAEC were used for additional mechanistic studies.<CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="56">The angiogenic threshold for roxarsone was between 0.001 and 0.01 &#181;M, an order of magnitude lower than the threshold for As<sup>III</sup> (<xref ref-type="fig" rid="f1-ehp0116-000520">Figures 1</xref> and <xref ref-type="fig" rid="f2-ehp0116-000520">2</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
          <s sid="57">As we have previously shown in <italic>in vivo</italic> chicken allantoic membrane angiogenesis assays (<xref ref-type="bibr" rid="b24-ehp0116-000520">Soucy et al. 2003</xref>), above 1 &#181;M As<sup>III</sup> becomes toxic to tube formation and inhibits angiogenesis (<xref ref-type="fig" rid="f2-ehp0116-000520">Figure 2</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/></s>
          <s sid="58">In contrast, even 10 &#181;M roxarsone showed no decrease in the angiogenic index (<xref ref-type="fig" rid="f1-ehp0116-000520">Figures 1</xref> and <xref ref-type="fig" rid="f2-ehp0116-000520">2</xref>) or signs of toxicity in the endothelial cells (data not shown).<CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/></s>
          <s sid="59">The fact that the efficacy for tube formation was similar, but the toxic potential differs, suggested that the two arsenicals differ in their mechanisms of action.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="60">Nitric oxide (NO) production is required for certain stimuli to promote angiogenesis (<xref ref-type="bibr" rid="b30-ehp0116-000520">Yu et al. 2005</xref>), but As<sup>III</sup> is known to promote reactive oxygen that limits available NO release in endothelial cells (<xref ref-type="bibr" rid="b2-ehp0116-000520">Barchowsky et al. 1999a</xref>, <xref ref-type="bibr" rid="b7-ehp0116-000520">Bunderson et al. 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
          <s sid="61">The data in <xref ref-type="fig" rid="f3-ehp0116-000520">Figure 3</xref> demonstrate that roxarsone requires NO generation to increase angiogenesis.<CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/></s>
          <s sid="62">Its effects were blocked by the eNOS inhibitor <sc>l</sc>-NG-nitroarginine methylester (L-NAME), but not its inactive enantiomer <sc>d</sc> -NG-nitroarginine methylester (D-NAME).<CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/></s>
          <s sid="63">In contrast, both NAME enantiomers prevented As<sup>III</sup> from increasing the angiogenic index.<CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/></s>
          <s sid="64">This would suggest either that As<sup>III</sup> inhibition by NAME was a nonstereospecific chemical effect or that D-NAME interacted with As<sup>III</sup> in a unique manner relative to roxarsone.<CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
          <s sid="65">Thus, roxarsone and inorganic As<sup>III</sup> appeared to have differential effects on signaling for NO-mediated angiogenesis.<CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="66">To investigate a possible mechanism for increased eNOS activity after exposure to arsenicals, we exposed HAEC to either roxarsone or As<sup>III</sup> for 0.5&#8211;4 hr, then probed for levels of serine phosphorylated eNOS relative to total eNOS.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/><CoreSc2 atype="GSC" type="Met" conceptID="Met9" novelty="None" advantage="None"/></s>
          <s sid="67">As shown in <xref ref-type="fig" rid="f4-ehp0116-000520">Figure 4</xref>, both arsenicals caused time-dependent increases in Ser1177 phosphorylation of eNOS.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/></s>
          <s sid="68">However, roxarsone caused a progressive increase over 4 hr, whereas As<sup>III</sup> caused a rapid stimulation of phosphorylation that was declining by 4 hr.<CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/></s>
          <s sid="69">These data indicate that the arsenicals do not share similar common upstream signaling actions that enhance the activity of AKT, a serine/threonine protein kinase, which commonly accounts for serine phosphorylation (<xref ref-type="bibr" rid="b10-ehp0116-000520">Dimmeler et al. 1999</xref>; <xref ref-type="bibr" rid="b11-ehp0116-000520">Fulton et al. 1999</xref>).<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
          <s sid="70">In addition, the time course for the effects of As<sup>III</sup> is consistent with its known ability to stimulate vascular NADPH oxidase to generate superoxide that quenches NO to form peroxynitrite (<xref ref-type="bibr" rid="b6-ehp0116-000520">Bunderson et al. 2002</xref>; <xref ref-type="bibr" rid="b18-ehp0116-000520">Lynn et al. 2000</xref>; <xref ref-type="bibr" rid="b23-ehp0116-000520">Smith et al. 2001</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/></s>
          <s sid="71">These oxidants often mediate inflammatory angiogenesis (<xref ref-type="bibr" rid="b28-ehp0116-000520">Ushio-Fukai and Alexander 2004</xref>) and thus may account for the mechanism of action for As<sup>III</sup>.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp3" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="72">Analysis of the effects of the two arsenicals on angiogenic gene activity further indicated that roxarsone and As<sup>III</sup> signal through distinct but overlapping mechanisms.<CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
          <s sid="73">Superarray quantitative PCR arrays of total RNA extracts from HMVEC treated with either arsenical for 24 hr demonstrated that the arsenicals differentially affect expression of a limited set of 9 of 84 inducible genes measured.<CoreSc1 atype="GSC" type="Res" conceptID="Res14" novelty="None" advantage="None"/></s>
          <s sid="74">As<sup>III</sup> induced more genes than it inhibited (<xref ref-type="table" rid="t2-ehp0116-000520">Table 2</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res15" novelty="None" advantage="None"/></s>
          <s sid="75">At 0.1 &#181;M, roxarsone inhibited more genes than it induced (<xref ref-type="table" rid="t2-ehp0116-000520">Table 2</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res16" novelty="None" advantage="None"/></s>
          <s sid="76">Several genes were affected in the same direction, but not to the same degree by the two agents.<CoreSc1 atype="GSC" type="Res" conceptID="Res17" novelty="None" advantage="None"/></s>
          <s sid="77">Both arsenicals decreased angiogenic repressive interferon 1<sub>a</sub> (<xref ref-type="bibr" rid="b27-ehp0116-000520">Strieter et al. 2005</xref>) and interferon-inducible CXCL9 transcripts.<CoreSc1 atype="GSC" type="Res" conceptID="Res18" novelty="None" advantage="None"/></s>
          <s sid="78">It was interesting that generally the higher roxarsone concentration (1.0 &#181;M) had either no effect on gene expression or the opposite effect of the low concentration.<CoreSc1 atype="GSC" type="Res" conceptID="Res19" novelty="None" advantage="None"/></s>
          <s sid="79">The exception was the concentration-dependent induction of hepatocyte growth factor (HGF) mRNA levels by both roxarsone concentrations.<CoreSc1 atype="GSC" type="Res" conceptID="Res20" novelty="None" advantage="None"/></s>
          <s sid="80">As<sup>III</sup> also strongly induced HGF transcripts.<CoreSc1 atype="GSC" type="Res" conceptID="Res21" novelty="None" advantage="None"/></s>
          <s sid="81">It is difficult to reconcile the differential effects of As<sup>III</sup> and the two concentrations of roxarsone on gene expression with their concentration-dependent effects on angiogenic potential.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot5" novelty="None" advantage="None"/></s>
          <s sid="82">It is possible that induction of a dominant factor, such as HGF, accounted for the observed increases in tube formation.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/></s>
          <s sid="83">However, the analysis was limited by the small number of gene changes measured and a lack of information regarding protein changes that may account for increased angiogenic index.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot6" novelty="None" advantage="None"/></s>
          <s sid="84">Although beyond the scope of the current studies, additional mechanistic experiments would delineate the linkage between any gene or protein change and increased angiogenic index after arsenical exposure.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot7" novelty="None" advantage="None"/></s>
          <s sid="85">Nonetheless, these data demonstrate that roxarsone and inorganic As<sup>III</sup> signal through different mechanisms to affect induction of genes that regulate angiogenesis.<CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec sec-type="conclusion">
        <title>Conclusion</title>
        <p>
          <s sid="86">Our results in human endothelial cell cultures demonstrate that roxarsone was a more potent inducer of angiogenesis than inorganic As<sup>III</sup>, and that roxarsone and As<sup>III</sup> signal through separate pathways to promote angiogenesis.<CoreSc1 atype="GSC" type="Con" conceptID="Con9" novelty="None" advantage="None"/></s>
          <s sid="87">The arsenicals had different time courses for phosphorylating eNOS; only the effects of roxarsone were blocked specifically by eNOS inhibition, and the two arsenicals differentially affected angiogenic gene induction.<CoreSc1 atype="GSC" type="Con" conceptID="Con10" novelty="None" advantage="None"/></s>
          <s sid="88">In addition to these differential effects, the fact that roxarsone is more potent for tube formation and less cytotoxic supports the conclusion that metabolism to inorganic As<sup>III</sup> cannot account for its vascular effects.<CoreSc1 atype="GSC" type="Con" conceptID="Con11" novelty="None" advantage="None"/></s>
          <s sid="89">More importantly, this was the first demonstration of functional vascular effects of roxarsone that may implicate a disease risk.<CoreSc1 atype="GSC" type="Con" conceptID="Con12" novelty="None" advantage="None"/></s>
          <s sid="90">Future studies are needed to demonstrate the mechanisms that enable differential signaling by the two arsenicals and the impact of this signaling in human endothelial cells on vascular disease promoted by their environmental exposures.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot8" novelty="None" advantage="None"/></s>
        </p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn>
          <p>We thank J. Stolz and D. Stolz for numerous stimulating discussions.</p>
        </fn>
        <fn>
          <p>P.B. was supported by National Research Service Award fellowship ES-1415201 from the National Institute of Environmental Health Sciences. Financial support from Duquesne University is also acknowledged.</p>
        </fn>
      </fn-group>
      <ref-list>
        <title>References</title>
        <ref id="b1-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Arai</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Lanzirotti</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Sutton</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Davis</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Sparks</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Arsenic speciation and reactivity in poultry litter</article-title>
            <source>Environ Sci Technol</source>
            <volume>37</volume>
            <fpage>4083</fpage>
            <lpage>4090</lpage>
          </citation>
        </ref>
        <ref id="b2-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Barchowsky</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Klei</surname>
                <given-names>LR</given-names>
              </name>
              <name name-style="western">
                <surname>Dudek</surname>
                <given-names>EJ</given-names>
              </name>
              <name name-style="western">
                <surname>Swartz</surname>
                <given-names>HM</given-names>
              </name>
              <name name-style="western">
                <surname>James</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <year>1999a</year>
            <article-title>Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite</article-title>
            <source>Free Radic Biol Med</source>
            <volume>27</volume>
            <fpage>1405</fpage>
            <lpage>1412</lpage>
          </citation>
        </ref>
        <ref id="b3-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Barchowsky</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Rousel</surname>
                <given-names>RR</given-names>
              </name>
              <name name-style="western">
                <surname>Klei</surname>
                <given-names>LR</given-names>
              </name>
              <name name-style="western">
                <surname>James</surname>
                <given-names>PE</given-names>
              </name>
              <name name-style="western">
                <surname>Ganju</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>KR</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1999b</year>
            <article-title>Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <volume>159</volume>
            <fpage>65</fpage>
            <lpage>75</lpage>
          </citation>
        </ref>
        <ref id="b4-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bhattacharjee</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>A sluggish response to humanity&#8217;s biggest mass poisoning</article-title>
            <source>Science</source>
            <volume>315</volume>
            <fpage>1659</fpage>
            <lpage>1661</lpage>
          </citation>
        </ref>
        <ref id="b5-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Brown</surname>
                <given-names>BL</given-names>
              </name>
              <name name-style="western">
                <surname>Slaughter</surname>
                <given-names>AD</given-names>
              </name>
              <name name-style="western">
                <surname>Schreiber</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <year>2004</year>
            <article-title>Controls on roxarsone transport in agricultural watersheds</article-title>
            <source>Appl Geochem</source>
            <volume>20</volume>
            <fpage>123</fpage>
            <lpage>133</lpage>
          </citation>
        </ref>
        <ref id="b6-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bunderson</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Coffin</surname>
                <given-names>JD</given-names>
              </name>
              <name name-style="western">
                <surname>Beall</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: possible role in atherosclerosis</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <volume>184</volume>
            <fpage>11</fpage>
            <lpage>18</lpage>
          </citation>
        </ref>
        <ref id="b7-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bunderson</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Pereira</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Schneider</surname>
                <given-names>MC</given-names>
              </name>
              <name name-style="western">
                <surname>Shaw</surname>
                <given-names>PK</given-names>
              </name>
              <name name-style="western">
                <surname>Coffin</surname>
                <given-names>JD</given-names>
              </name>
              <name name-style="western">
                <surname>Beall</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Manganese enhances peroxynitrite and leukotriene E4 formation in bovine aortic endothelial cells exposed to arsenic</article-title>
            <source>Cardiovasc Toxicol</source>
            <volume>6</volume>
            <fpage>15</fpage>
            <lpage>23</lpage>
          </citation>
        </ref>
        <ref id="b8-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Chapman</surname>
                <given-names>HD</given-names>
              </name>
              <name name-style="western">
                <surname>Johnson</surname>
                <given-names>ZB</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>Use of antibiotics and roxarsone in broiler chickens in the USA: Analysis for the years 1995 to 2000</article-title>
            <source>Poult Sci</source>
            <volume>81</volume>
            <fpage>356</fpage>
            <lpage>364</lpage>
          </citation>
        </ref>
        <ref id="b9-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Factor-Litvak</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Howe</surname>
                <given-names>GR</given-names>
              </name>
              <name name-style="western">
                <surname>Graziano</surname>
                <given-names>JH</given-names>
              </name>
              <name name-style="western">
                <surname>Brandt-Rauf</surname>
                <given-names>P</given-names>
              </name>
              <name name-style="western">
                <surname>Parvez</surname>
                <given-names>F</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study</article-title>
            <source>Am J Epidemiol</source>
            <volume>165</volume>
            <fpage>541</fpage>
            <lpage>552</lpage>
          </citation>
        </ref>
        <ref id="b10-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Dimmeler</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Fleming</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Fisslthaler</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Hermann</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Busse</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Zeiher</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <year>1999</year>
            <article-title>Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation</article-title>
            <source>Nature</source>
            <volume>399</volume>
            <fpage>601</fpage>
            <lpage>605</lpage>
          </citation>
        </ref>
        <ref id="b11-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Fulton</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Gratton</surname>
                <given-names>JP</given-names>
              </name>
              <name name-style="western">
                <surname>McCabe</surname>
                <given-names>TJ</given-names>
              </name>
              <name name-style="western">
                <surname>Fontana</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Fujio</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Walsh</surname>
                <given-names>K</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1999</year>
            <article-title>Regulation of endothelium-derived nitric oxide production by the protein kinase Akt</article-title>
            <source>Nature</source>
            <volume>399</volume>
            <fpage>597</fpage>
            <lpage>601</lpage>
          </citation>
        </ref>
        <ref id="b12-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Garbarino</surname>
                <given-names>JR</given-names>
              </name>
              <name name-style="western">
                <surname>Bednar</surname>
                <given-names>AJ</given-names>
              </name>
              <name name-style="western">
                <surname>Rutherford</surname>
                <given-names>DW</given-names>
              </name>
              <name name-style="western">
                <surname>Beyer</surname>
                <given-names>RS</given-names>
              </name>
              <name name-style="western">
                <surname>Wershaw</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <year>2003</year>
            <article-title>Environmental fate of roxarsone in poultry litter. I. Degradation of roxarsone during composting</article-title>
            <source>Environ Sci Technol</source>
            <volume>37</volume>
            <fpage>1509</fpage>
            <lpage>1514</lpage>
          </citation>
        </ref>
        <ref id="b13-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ghosh</surname>
                <given-names>RN</given-names>
              </name>
              <name name-style="western">
                <surname>Lapets</surname>
                <given-names>O</given-names>
              </name>
              <name name-style="western">
                <surname>Haskins</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Characteristics and value of directed algorithms in high content screening</article-title>
            <source>Methods Mol Biol</source>
            <volume>356</volume>
            <fpage>63</fpage>
            <lpage>81</lpage>
          </citation>
        </ref>
        <ref id="b14-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Grove</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Ghosh</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Quantitative characterization of mitosis-blocked tetraploid cells using high content analysis</article-title>
            <source>Assay Drug Dev Technol</source>
            <volume>4</volume>
            <fpage>421</fpage>
            <lpage>442</lpage>
          </citation>
        </ref>
        <ref id="b15-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kamat</surname>
                <given-names>CD</given-names>
              </name>
              <name name-style="western">
                <surname>Green</surname>
                <given-names>DE</given-names>
              </name>
              <name name-style="western">
                <surname>Curilla</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Warnke</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Hamilton</surname>
                <given-names>JW</given-names>
              </name>
              <name name-style="western">
                <surname>Sturup</surname>
                <given-names>S</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration</article-title>
            <source>Toxicol Sci</source>
            <volume>86</volume>
            <fpage>248</fpage>
            <lpage>257</lpage>
          </citation>
        </ref>
        <ref id="b16-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lasky</surname>
                <given-names>T</given-names>
              </name>
              <name name-style="western">
                <surname>Sun</surname>
                <given-names>W</given-names>
              </name>
              <name name-style="western">
                <surname>Kadry</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Hoffman</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <year>2004</year>
            <article-title>Mean total arsenic concentrations in chicken 1989&#8211;2000 and estimated exposures for consumers of chicken</article-title>
            <source>Environ Health Perspect</source>
            <volume>112</volume>
            <fpage>18</fpage>
            <lpage>21</lpage>
          </citation>
        </ref>
        <ref id="b17-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Pan</surname>
                <given-names>SG</given-names>
              </name>
              <name name-style="western">
                <surname>Dong</surname>
                <given-names>XS</given-names>
              </name>
              <name name-style="western">
                <surname>Qiao</surname>
                <given-names>HQ</given-names>
              </name>
              <name name-style="western">
                <surname>Jiang</surname>
                <given-names>HC</given-names>
              </name>
              <name name-style="western">
                <surname>Krissansen</surname>
                <given-names>GW</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2006</year>
            <article-title>Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice</article-title>
            <source>Cancer Sci</source>
            <volume>7</volume>
            <fpage>675</fpage>
            <lpage>681</lpage>
          </citation>
        </ref>
        <ref id="b18-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lynn</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Gurr</surname>
                <given-names>JR</given-names>
              </name>
              <name name-style="western">
                <surname>Lai</surname>
                <given-names>HT</given-names>
              </name>
              <name name-style="western">
                <surname>Jan</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells</article-title>
            <source>Circ Res</source>
            <volume>86</volume>
            <fpage>514</fpage>
            <lpage>519</lpage>
          </citation>
        </ref>
        <ref id="b19-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Morrison</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <year>1969</year>
            <article-title>Distribution of arsenic from poultry litter in broiler chickens, soil, and crops</article-title>
            <source>J Agric Food Chem</source>
            <volume>17</volume>
            <fpage>1288</fpage>
            <lpage>1290</lpage>
          </citation>
        </ref>
        <ref id="b20-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Navas-Acien</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Sharrett</surname>
                <given-names>AR</given-names>
              </name>
              <name name-style="western">
                <surname>Silbergeld</surname>
                <given-names>EK</given-names>
              </name>
              <name name-style="western">
                <surname>Swhartz</surname>
                <given-names>BS</given-names>
              </name>
              <name name-style="western">
                <surname>Nachman</surname>
                <given-names>KE</given-names>
              </name>
              <name name-style="western">
                <surname>Burke</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Arsenic exposure and cardiovascular disease: a systematic review of the epidemio-logic evidence</article-title>
            <source>Am J Epidemiol</source>
            <volume>162</volume>
            <fpage>1037</fpage>
            <lpage>1049</lpage>
          </citation>
        </ref>
        <ref id="b21-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>O&#8217;Connor</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>O&#8217;Connor</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Irgolic</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Sabrsula</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>Guerleyuek</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Brunette</surname>
                <given-names>R</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Transformations, air transport, and human impact of arsenic from poultry litter</article-title>
            <source>Environ Forensics</source>
            <volume>6</volume>
            <fpage>83</fpage>
            <lpage>89</lpage>
          </citation>
        </ref>
        <ref id="b22-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Sapkota</surname>
                <given-names>AR</given-names>
              </name>
              <name name-style="western">
                <surname>Lefferts</surname>
                <given-names>LY</given-names>
              </name>
              <name name-style="western">
                <surname>McKenzie</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Walker</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>What do we feed to food-production animals? A review of animal feed ingredients and their potential impacts on human health</article-title>
            <source>Environ Health Perspect</source>
            <volume>115</volume>
            <fpage>663</fpage>
            <lpage>670</lpage>
          </citation>
        </ref>
        <ref id="b23-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>KR</given-names>
              </name>
              <name name-style="western">
                <surname>Klei</surname>
                <given-names>LR</given-names>
              </name>
              <name name-style="western">
                <surname>Barchowsky</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells</article-title>
            <source>Am J Physiol</source>
            <volume>280</volume>
            <fpage>L442</fpage>
            <lpage>L449</lpage>
          </citation>
        </ref>
        <ref id="b24-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Soucy</surname>
                <given-names>NV</given-names>
              </name>
              <name name-style="western">
                <surname>Ihnat</surname>
                <given-names>MA</given-names>
              </name>
              <name name-style="western">
                <surname>Kamat</surname>
                <given-names>CD</given-names>
              </name>
              <name name-style="western">
                <surname>Hess</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Post</surname>
                <given-names>MJ</given-names>
              </name>
              <name name-style="western">
                <surname>Klei</surname>
                <given-names>LR</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2003</year>
            <article-title>Arsenic stimulates angiogenesis and tumorigenesis in vivo</article-title>
            <source>Toxicol Sci</source>
            <volume>76</volume>
            <fpage>271</fpage>
            <lpage>279</lpage>
          </citation>
        </ref>
        <ref id="b25-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Soucy</surname>
                <given-names>NV</given-names>
              </name>
              <name name-style="western">
                <surname>Mayka</surname>
                <given-names>DD</given-names>
              </name>
              <name name-style="western">
                <surname>Klei</surname>
                <given-names>LR</given-names>
              </name>
              <name name-style="western">
                <surname>Nemec</surname>
                <given-names>AA</given-names>
              </name>
              <name name-style="western">
                <surname>Bauer</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Barchowsky</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice</article-title>
            <source>Cardiovasc Toxicol</source>
            <volume>5</volume>
            <fpage>29</fpage>
            <lpage>41</lpage>
          </citation>
        </ref>
        <ref id="b26-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Stolz</surname>
                <given-names>JF</given-names>
              </name>
              <name name-style="western">
                <surname>Perera</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Kilonzo</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Kail</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Crable</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Fisher</surname>
                <given-names>E</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Biotransformation of 3-nitro-4-hydroxybenzene arsonic acid (roxarsone) and release of inorganic arsenic by Clostridium species</article-title>
            <source>Environ Sci Technol</source>
            <volume>41</volume>
            <fpage>818</fpage>
            <lpage>823</lpage>
          </citation>
        </ref>
        <ref id="b27-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Strieter</surname>
                <given-names>RM</given-names>
              </name>
              <name name-style="western">
                <surname>Burdick</surname>
                <given-names>MD</given-names>
              </name>
              <name name-style="western">
                <surname>Gomperts</surname>
                <given-names>BN</given-names>
              </name>
              <name name-style="western">
                <surname>Belperio</surname>
                <given-names>JA</given-names>
              </name>
              <name name-style="western">
                <surname>Keane</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <year>2005</year>
            <article-title>CXC chemokines in angiogenesis</article-title>
            <source>Cytokine Growth Factor Rev</source>
            <volume>16</volume>
            <fpage>593</fpage>
            <lpage>609</lpage>
          </citation>
        </ref>
        <ref id="b28-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ushio-Fukai</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Alexander</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <year>2004</year>
            <article-title>Reactive oxygen species as mediators of angiogenesis signaling. Role of NAD(P)H oxidase</article-title>
            <source>Mol Cell Biochem</source>
            <volume>264</volume>
            <fpage>84</fpage>
            <lpage>97</lpage>
          </citation>
        </ref>
        <ref id="b29-ehp0116-000520">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Wallinga</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <source>Playing Chicken: Avoiding Arsenic in Your Meat</source>
            <publisher-loc>Minneapolis, MN</publisher-loc>
            <publisher-name>Institute for Agriculture and Trade Policy</publisher-name>
          </citation>
        </ref>
        <ref id="b30-ehp0116-000520">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Yu</surname>
                <given-names>J</given-names>
              </name>
              <name name-style="western">
                <surname>deMuinck</surname>
                <given-names>ED</given-names>
              </name>
              <name name-style="western">
                <surname>Zhuang</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Drinane</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Kauser</surname>
                <given-names>K</given-names>
              </name>
              <name name-style="western">
                <surname>Rubanyi</surname>
                <given-names>GM</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve</article-title>
            <source>Proc Natl Acad Sci USA</source>
            <volume>102</volume>
            <fpage>10999</fpage>
            <lpage>11004</lpage>
          </citation>
        </ref>
      </ref-list>
    </back>
  </article>
</PAPER>